Best GLP-1 telehealth program in 2026: comparison of legitimate options

The 2026 telehealth landscape has consolidated

The 2022-2024 telehealth boom (Hims, Sequence, Push Health, dozens of platforms) was heavily subsidized by compounded semaglutide margins. When compounded GLP-1 wound down in early 2026, much of that ecosystem contracted. Major platforms either exited compounded and pivoted to branded-only, or exited GLP-1 entirely.

What remains in 2026: legitimate platforms prescribing FDA-approved branded GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, orforglipron). Plus manufacturer direct-to-consumer paths from Novo Nordisk and Eli Lilly.

Ro (Ro Body) — clinical concierge model

Approach: physician-led clinical service with medication management, lab monitoring, and dietitian access. Premium tier in the market.

Drugs prescribed: branded Wegovy, Zepbound, Ozempic, Mounjaro (when clinically appropriate), orforglipron. Insurance handling included.

Cost: monthly subscription ~$135 plus medication cost (insurance copay or manufacturer self-pay). Total cost varies widely based on insurance.

Best for: patients who want hands-on clinical guidance, prior authorization help, and lifestyle support integrated. Not the cheapest option but the most comprehensive.

Caveats: subscription fee is on top of medication. Some patients find the high-touch model excessive if they just want the prescription.

Sequence (Weight Watchers) — lifestyle integration

Approach: GLP-1 prescription combined with WW behavioral program. Heavy emphasis on lifestyle change supporting the medication.

Drugs prescribed: branded Wegovy primarily. Zepbound and Ozempic in some cases. Compounded discontinued.

Cost: monthly subscription ~$99 plus medication cost. Sometimes bundled with insurance handling.

Best for: patients who want behavioral/dietary structure alongside medication. WW's track record of behavioral support is well-established.

Caveats: not the cheapest paths for medication-only patients. Lifestyle program adds cost some patients don't need.

Calibrate — high-touch coaching

Approach: 12-month structured program with heavy coaching, metabolic monitoring, and medication management.

Drugs prescribed: branded Wegovy, Zepbound primarily. Insurance handling and PA support included.

Cost: $1,649 for 12-month program plus medication. Premium pricing for premium service.

Best for: patients seeking structured long-term commitment to metabolic transformation. Strong evidence of weight loss in their published outcomes.

Caveats: substantial upfront commitment. Limited flexibility if life circumstances change mid-program.

NovoCare and LillyDirect — manufacturer direct

Approach: direct-from-manufacturer programs. Less clinical support, more streamlined dispensing.

NovoCare drugs: Wegovy ($499/month self-pay), Ozempic (T2D path). Telehealth partner network for prescribing.

LillyDirect drugs: Zepbound vials ($349-549/month), orforglipron ($149/month), Mounjaro for T2D. Telehealth partner network.

Best for: cost-driven patients who want manufacturer programs without telehealth subscription fees on top.

Caveats: less clinical support than full-service platforms. You're responsible for understanding dose escalation, side-effect management, and monitoring. Works well for patients who feel confident managing their own care.

How to choose based on your situation

If you have commercial insurance with Wegovy coverage: any platform what handles PA well works. Ro and Calibrate excel at PA navigation. Your monthly cost = subscription + $0-$50 copay.

If you have insurance but Wegovy is excluded: NovoCare self-pay $499/mo for Wegovy, OR LillyDirect for orforglipron $149/mo. Skip the subscription platforms — they don't help when insurance doesn't cover.

If you have no insurance: LillyDirect orforglipron $149/mo is the cheapest legitimate path. NovoCare $499/mo for Wegovy if you specifically want injectable semaglutide.

If you have T2D: Mounjaro or Ozempic on commercial insurance is straightforward. Coverage is broad. Any platform or direct manufacturer access works.

If you want maximum coaching: Calibrate. If you want clinical concierge: Ro. If you want behavioral support: Sequence/WW.

Red flags to avoid

'No prescription required' offers. Illegal in the US. Almost certainly imported unapproved bulk material.

Prices below $100/month for legitimate FDA-approved GLP-1. Orforglipron at $149 is the floor. Anything lower is either compounded (regulatory grey zone) or illegal.

Mail-order from foreign pharmacies. Quality unknown, FDA cannot verify, US regulatory protections don't apply.

Platforms that recently exited compounded and pivoted to branded in early 2026. Some have legitimate operations now; others are struggling and may have compromised clinical oversight. Check recent reviews and regulatory actions before committing.